Article of Interest
Article Detail
Author
Name: Susan Ward, CPC, CPC-H, CPC-I, CEMC, CPCD, CPRC
Article Date: MARCH
2014
Title: Code Mohs in 6 Easy Steps
Source: AAPC
Look for location, stages, and tissue blocks in documentation
When reporting
Mohs surgery for treatment of skin cancer, documentation must confirm that a
single provider acted as both the surgeon and pathologist. From there, you need
only know the location of the treated lesion, plus the number of “stages” and
required tissue blocks, to select an appropriate code.
Step 1:
Confirm the Surgeon and Pathologist Are the Same
Confirm the Surgeon and Pathologist Are the Same
Mohs requires
that a single physician act as both surgeon (excising tissue) and pathologist
(immediately examining excised tissue to determine clear margins). Per CPT®,
“if either of these responsibilities is delegated to another physician or
qualified health care professional who reports the services separately, the …
[Mohs] codes should not be reported.”
Step 2: Identify
Location
CPT®
categorizes Mohs procedures by location:
For lesions of
the head, neck, hands, feet, and genitalia, or any location with surgery
directly involving muscle, cartilage, bone, tendon, major nerves, or vessels,
look to code 17311 and add-on code 17312.
For lesions of
the trunk, arms, and legs, select code 17313 and add-on code 17314.
Regardless of
location, you might also need to report add-on code 17315, as explained in the Mohs
Code Definitions sidebar.
Step 3:
How Many Stages?
How Many Blocks?
How Many Stages?
How Many Blocks?
Things become
more complicated at this step. It helps greatly if you understand what the
surgeon/pathologist does in the procedure room.
To spare as
much healthy tissue as possible (while still eradicating cancerous cells), the
physician removes tissue in stages. The first stage is to excise the
lesion. The specimen is divided into smaller portions, called blocks.
Per CPT®, “a
tissue block … is defined as an individual tissue piece embedded in a mounting
medium for sectioning.” The location of each block within the stage is
carefully mapped, and each block is examined for cancer cells.
Where the
surgeon sees a clear margin (no malignant tissue), no further excision is
necessary beyond that block. Where the physician finds malignancy, a further
stage is required to remove additional material (this is the second stage,
which is again divided into blocks). The process continues until no further cancer
cells are identified.
Bottom line: Each time the
surgeon excises material counts as a stage. Each slide resulting from an
individual stage counts as a block.
Step 4:
Separately Consider
Each Lesion Treated
Separately Consider
Each Lesion Treated
If the
surgeon/pathologist uses the Mohs technique on multiple lesions during the same
session, code for each lesion separately.
Step 5: Put It All
Together
Using steps
1-4, test your skills with these coding scenarios.
Scenario 1: The patient
presents with a basal cell carcinoma of the central portion of the forehead.
After prepping the patient and site, the physician removes the carcinoma (first
stage) and divides it into four tissue blocks for examination. Upon microscopic
examination, the physician finds the margins are clear of carcinoma.
The appropriate
coding would be:
CPT®: 17311
ICD-9-CM:
173.31
Basal cell carcinoma of skin of other and unspecified parts of face
Basal cell carcinoma of skin of other and unspecified parts of face
Scenario 2: The patient
presents with a squamous cell carcinoma of the nose. After prepping the patient
and site, the physician removes the carcinoma (first stage) and divides the
stages into six tissue blocks for examination. Upon microscopic examination,
the physician finds there are positive margins. He removes the positive margin
with another excision (second stage), which is divided into three tissue blocks
for examination. Upon microscopic examination, the physician finds the margins
are negative.
The appropriate
coding would be:
CPT®: 17311
(first stage)
+17312 (second
stage)
+17315 (six
blocks)
ICD-9-CM:
173.32
Squamous cell carcinoma of skin of other and unspecified parts of face
Squamous cell carcinoma of skin of other and unspecified parts of face
Scenario 3: The patient
presents with three skin cancers: basal cell carcinoma of the right neck,
squamous cell carcinoma of the right hand, and squamous cell carcinoma of the
left ala. After prepping the patient and the sites, the physician first removes
the BCC of the neck. He divides it into two tissue blocks. Under microscopic
examination, the margins are negative. Next, the physician removes the SCC of
the hand, dividing that stage into three tissue blocks. Under microscopic
examination, the margins are negative. Lastly, the physician removes the SCC of
the left ala, dividing the stage into six blocks. Under microscopic
examination, there is a positive margin. The physician then takes a second stage,
which is divided into two blocks. Under microscopic examination the margins are
negative.
The appropriate
coding in this scenario is:
CPT®:
17311 (neck)
17311-59 Distinct
procedural service (hand)
17311-59 (nose)
17312 (second
stage of nose)
17315 (extra
block of first stage of nose)
ICD-9-CM:
173.41 Basal
cell carcinoma of scalp and skin of neck
173.62
Squamous cell carcinoma of skin of upper limb, including shoulder
Squamous cell carcinoma of skin of upper limb, including shoulder
173.32 (nose)
Tip: Refer to the
ICD-9-CM neoplasm table for the most appropriate diagnosis for the patient’s
skin cancer.
Step 6:
Be on the Lookout for Separate Procedures
Be on the Lookout for Separate Procedures
The physician
may need to conduct additional procedures during the same encounter as a Mohs
procedure. Depending on the procedure and the circumstances, you may be able to
separately report additional work.
Biopsy and
Histopathologic Exam
Because
histopathologic examination is included in the Mohs procedure, you may not
separately report pathology codes 88302-88309. Likewise, you would not
typically report biopsy separately with a Mohs procedure.
The exception
to this rule occurs when there is “no prior pathology confirmation of a
diagnosis,” according to CPT®. In such a case, the same-day biopsy (11100 Biopsy of skin, subcutaneous tissue and/or
mucous membrane (including simple closure), unless otherwise listed; single
lesion, +11101 Biopsy of skin,
subcutaneous tissue and/or mucous membrane (including simple closure), unless
otherwise listed; each separate/additional lesion (List separately in addition
to code for primary procedure)), and frozen section pathology (88331 Pathology consultation during surgery; first
tissue block, with frozen section(s), single specimen) may be reported
separately, in addition to the Mohs surgery. You must append modifier 59 Distinct
procedural service to the biopsy and pathology codes to confirm
these procedures are not a routine part of the Mohs procedure.
For example, a
new or established patient is seen in clinic for a routine skin check. During
the examination, the provider identifies a suspicious lesion of the left cheek.
After discussion with the patient on treatment options, the patient consents to
a biopsy of the lesion. The area is prepped and draped in a sterile fashion,
with the use of a 3 mm punch tool. The provider takes a biopsy of the lesion.
The specimen is then prepared for frozen section, and is found to be positive
for BCC. With the patient’s permission, the physician performs a single stage
Mohs in removing the carcinoma.
In this
example, the proper reporting would be:
CPT®:
17311 (for the
Mohs surgery of the cheek)
11100-59 (for
the biopsy)
88331-59 (for
the frozen section of the biopsy)
Stains
Mohs surgery
includes “routine stains,” such as hematoxylin and eosin (H&E) or toluidine
blue. If the physician performs an additional, atypical stain, you may report
the appropriate special stain code. CPT® instructs, “When a nonroutine
histochemical stain on frozen tissue is utilized, report +88314 [Special
stains (List separately in addition to code for primary service); histochemical
staining with frozen section(s)] with modifier 59.”
Repair of
Surgical Wounds
CPT® instructs,
“If a repair is performed, use separate repair, flap, or graft codes.”
For example, in
scenario 3, the surgeon/pathologist closes the surgical wound using a cheek
rotation flap measuring 5.2 cm2. In this case, correct coding would allow you
to separately report 14040 Adjacent tissue transfer or rearrangement,
forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet;
defect 10 sq cm or less. Because treatment is directed at the suspicious
lesion, which was proven to be carcinoma, your diagnosis for the entire
encounter would be 173.31.
Mohs Code
Definitions
17311 Mohs
micrographic technique, including removal of all gross tumor, surgical excision
of tissue specimens, mapping, color coding of specimens, microscopic
examination of specimens by the surgeon, and histopathologic preparation
including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), head
neck, hands, feet, genitalia or any location with surgery directly involving
muscle, cartilage, bone, tendon, major nerves or vessels; first stage, up to 5
tissue blocks
+17312 each
additional stage after the first stage, up to 5 tissue blocks (list separately
in addition to code for primary procedure)
Report 17312
only with 17311.
17313 Mohs
micrographic technique, including removal of all gross tumor, surgical excision
of tissue specimens, mapping, color coding of specimens, microscopic
examination of specimens by the surgeon, and histopathologic preparation
including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), of the
trunk, arms or legs; first stage, up to 5 tissue blocks
+17314 each
additional stage after the first stage, up to 5 tissue blocks (list separately
in addition to code for primary procedure)
Report 17314
only with 17313.
Codes
17311-17314 define “up to five tissue blocks.” If a single stage must be
divided into more than five blocks, you may report an add-on code for each
additional block beyond the initial five.
+17315 Mohs
micrographic technique, including removal of all gross tumor, surgical excision
of tissue specimens, mapping, color coding of specimens, microscopic
examination of specimens by the surgeon, and histopathologic preparation
including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), each
additional block after the first 5 tissue blocks, any stage (list separately in
addition to code for primary procedure)
You may report
17315 with all codes 17311-17314, when appropriate.

No comments:
Post a Comment